Lv52
1120 积分 2022-06-07 加入
Real-world effectiveness, safety and immunogenicity of ocrelizumab in turkish multiple sclerosis patients: a single-center experience for 4-year follow-up
21天前
已关闭
Comparison of 10-year Survival Outcomes between CT Surveillance and Surgery for Ground-Glass Nodules
27天前
已完结
Sleep breathing disorders in pediatric patients with spinal muscular atrophy 2
1个月前
已完结
Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report
1个月前
已完结
NLRP3 Inflammasome Activation Contributes to Seizure Susceptibility in Anti-NMDAR Encephalitis: Evidence from Patients and a Mouse Model
1个月前
已完结
Harnessing patient-derived antibodies-induced microglial complement 1q expression: Novel therapy for anti-NMDAR encephalitis
1个月前
已完结
Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis
1个月前
已完结
What Are the Proposed Mechanisms Contributing to the Manifestations of Anti-NMDAR Encephalitis?
1个月前
已完结
Systematic review on the wearing-off phenomenon of disease-modifying therapies in managing multiple sclerosis
1个月前
已关闭
Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study
1个月前
已关闭
皖公网安备34019202002308
